Evidence map›Paper›PMID 36973488›Full record

ArticleCellular & molecular immunology2023

TAK1 is essential for MAIT cell development and the differentiation of MAIT1 and MAIT17.

Rachel Krevh, Jie Wang, Bobby Zuniga, Jugmohit Toor, Kalpana Subedi, Li Zhou, Qing-Sheng Mi

Abstract readLetter
In one paragraph

Article in Cellular & molecular immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Rachel Krevh *Center for Cutaneous Biology and Immunology Research, Department of Dermatology, Henry Ford Health, Detroit, MI, USA.
Jie Wang *Center for Cutaneous Biology and Immunology Research, Department of Dermatology, Henry Ford Health, Detroit, MI, USA.
Bobby ZunigaCenter for Cutaneous Biology and Immunology Research, Department of Dermatology, Henry Ford Health, Detroit, MI, USA.ORCID http://orcid.org/0000-0001-5699-4671
Jugmohit ToorCenter for Cutaneous Biology and Immunology Research, Department of Dermatology, Henry Ford Health, Detroit, MI, USA.
Kalpana SubediCenter for Cutaneous Biology and Immunology Research, Department of Dermatology, Henry Ford Health, Detroit, MI, USA.
Li ZhouCenter for Cutaneous Biology and Immunology Research, Department of Dermatology, Henry Ford Health, Detroit, MI, USA. lzhou1@hfhs.org.
Qing-Sheng MiCenter for Cutaneous Biology and Immunology Research, Department of Dermatology, Henry Ford Health, Detroit, MI, USA. QMI1@hfhs.org.ORCID http://orcid.org/0000-0002-1411-6827

Funding

microRNAs and NKT cell development and functionR01AI119041 · NIAID · HENRY FORD HEALTH SYSTEM · PI MI, QING-SHENG · 2016 to 2020
$1.8M
NIAID NIH HHS R01 AI119041
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Mucosal-Associated Invariant T CellsCell DifferentiationMAP Kinase Kinase KinasesMAP Kinase Kinase Kinases

Identifiers

PMID36973488
PMCPMC10310715

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.